 |
|
Address
Columbia University/NYSPI, 1051 Riverside Drive, Box 123
New York, 10032
Phone:212-923-8862
Fax: 212-543-5913
Email:[email protected]
|
|
Education and Training
| PhD
| 1986
| Columbia University
|
| MS
| 1980
| Columbia University
|
| BA
| 1972
| University of California
|
|
|
|
|
Professor of Clinical Epidemiology (in Psychiatry), Mailman School of Public Health
and:
Department of Psychiatry, College of Physicians and Surgeons
|
| Dr. Hasin’s research focuses on alcohol and drug disorders and related comorbidity. She has a joint appointment in the Department of Psychiatry at Columbia, is a research scientist at New York State Psychiatric Institute, and has published over 150 papers. Dr. Hasin’s research covers several areas, including gene-environment interaction, nosology (basic conceptions of disorders), factors affecting longitudinal course, and the nature of comorbidity between substance and psychiatric disorders. She is an internationally recognized expert who has participated in World Health Organization studies, recently completed a two-year term as head of the Measurement Group for the national NIDA Clinical Trials Network, and is a current member of the American Psychiatric Association’s DSM-V workgroup on substance use disorders. Dr. Hasin has received extensive research funding from the National Institutes of Health, including three current grants. Studies in Dr. Hasin’s research group include gene-environment interaction in the etiology of alcohol, nicotine and drug use in Israel, novel phenotype development for genetics studies of substance abuse disorders, analyses of national and longitudinal cohort studies of alcohol and drug disorders, and a clinical trial of a technologically enhanced brief drinking-reduction intervention in HIV primary care patients. Dr. Hasin’s diagnostic research instrument, the PRISM, is in use in numerous studies of the relationship of substance and psychiatric disorders.
|
|
|
|
|
